Pricing Log in Create free account

InterCure Ltd. (INCR) vs Incannex Healthcare Inc. (IXHL)

InterCure Ltd. and Incannex Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. InterCure Ltd. is the larger, with a market value of $39.1M against $28.5M — 1.4× the size. Incannex Healthcare Inc. has negative trailing earnings, so its P/E is not meaningful; InterCure Ltd. trades at 6.2×. InterCure Ltd. has the higher net margin (4.88% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, InterCure Ltd. leads on 10 and Incannex Healthcare Inc. on 5.

Valuation

Metric INCR IXHL Drug Manufacturers Specialty & Generic median
P/E 6.23 n/m 20.55
P/S 0.24 16.88 2.08
P/B 0.23 0.39 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 6.17 1.65 12.22
EV/Sales 0.56 (24.08) 2.87
Earnings yield 16.05% (75.75%) (15.94%)
Free cash flow yield (2.85%) (48.87%) 0.00%

Profitability

Metric INCR IXHL Drug Manufacturers Specialty & Generic median
Gross margin 32.74% (0.10%) 53.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 4.88% 0.00% (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (47.80%) (0.80%)
Return on assets 0.00% (41.32%) (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INCR IXHL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 16.15% — 5.22%
EPS growth (last fiscal year) 52.50% 95.91% 42.91%
Revenue growth, 5-year CAGR 31.11% (29.64%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INCR IXHL Drug Manufacturers Specialty & Generic median
Debt to equity 0.27 0.00 0.04
Current ratio 1.85 48.81 2.41
Net debt to EBITDA (4.07) 2.97 1.01

Dividend

Metric INCR IXHL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric INCR IXHL Drug Manufacturers Specialty & Generic median
Market cap 39.05m 28.47m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack